Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30

$0.36−0.03 (-8.70%)

Close on Nov 12, 2026Market cap $3.15MP/E 0.3Yield –

Evogene ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$12.89M. The highest annual figure on record is -$12.89M in fiscal 2025.

Annual ebitda

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$12.89M	–
FY2024	Dec 31, 2024	-$17.42M	–
FY2023	Dec 31, 2023	-$20.93M	–
FY2022	Dec 31, 2022	-$25.43M	–
FY2021	Dec 31, 2021	-$29.65M	–
FY2020	Dec 31, 2020	-$23.02M	–
FY2019	Dec 31, 2019	-$18.77M	–
FY2018	Dec 31, 2018	-$17.97M	–
FY2017	Dec 31, 2017	-$19.80M	–
FY2016	Dec 31, 2016	-$18.81M	–
FY2015	Dec 31, 2015	-$15.49M	–

Where these numbers come from

Parsed from the XBRL in Evogene's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Jul 25, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EVGN.

Compare: EVGN vs CBUS · EVGN vs SNES · EVGN vs DYAI · EVGN vs PRPH · EVGN vs PTCHF

Revenue growth-30.9% · median 2.7%

Gross margin-6.3% · median 16.8%

Operating margin-364.2% · median -354.1%

Net margin-220.2% · median -439.3%

Company	Revenue	Growth
CBUS	$4.53M	+19.5%
EVGN	$3.85M	-30.9%
PRPH	$3.85M	-31.2%
DYAI	$3.80M	-8.0%
SNES	$2.37M	+13.4%
PTCHF	–	–

Company

Exchange: Nasdaq
Industry: Agricultural Chemicals
Fiscal year ends: December 31
Employees: 78
Held by institutions: 3.2%
Auditor: KOST FORER GABBAY & KASIERER
SEC CIK: 1574565

Advertisement
300 × 250

See a number that looks wrong?